Clinical Trial Update: Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes ongoing Phase 2/Phase 3 evaluation of haloperidol and lorazepam to manage persistent agitated delirium in patients with advance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Delirium

Drugs mentioned

• Ativan (Lorazepam)
• Haldol (haloperidol)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Delirium, Locally Advanced Malignant Neoplasm | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING